Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Maridebart Cafraglutide

MARITIME-1

Amgen · Phase 3 · Active, not recruiting · Enrollment 3853

NCT06858839

ArmPopulationDoseWeeksEstimandWeight change
Maridebart Cafraglutide High DosePopulation n/rn/rn/rn/rn/r
Maridebart Cafraglutide Medium DosePopulation n/rn/rn/rn/rn/r
Maridebart Cafraglutide Low DosePopulation n/rn/rn/rn/rn/r
PlaceboPopulation n/rn/rn/rn/rn/r